search
Pfizer
Trends
- 1Pfizer highlights AI's role in speeding clinical trial matching●How AI Is Helping Match Patients to Clinical Trials Faster
Pfizer is drawing attention to how artificial intelligence is being used to match patients to clinical trials more quickly. AI tools can scan patient records and trial criteria far faster than manual screening, helping to address the long-standing problem that many trials struggle to enrol enough participants. The topic is part of a wider debate about AI's growing role in drug development and patient care.
- 2Former Pfizer Executive Bill Sessa Named Chair of Isomab Advisory Board▼Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board
Professor Bill Sessa, formerly Chief Scientific Officer of Internal Medicine at Pfizer, has been appointed Chair of Isomab's Scientific Advisory Board. The move gives the biotech company a senior figure with decades of large-pharma experience as it advances its scientific programmes, and the announcement was distributed via PR Newswire.